Use of PPD for the adjuvantation of a nucleic acid vaccine

Details for Australian Patent Application No. 2007263355 (hide)

Owner Transgene S.A.

Inventors Bonnefoy, Jean-Yves; Paul, Stephane; Limacher, Jean-Marc

Agent Freehills

Pub. Number AU-A-2007263355

PCT Pub. Number WO2007/147518

Priority 06360026.6 20.06.06 EP; 60/853,019 20.10.06 US

Filing date 14 June 2007

Wipo publication date 27 December 2007

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/147518 Priority application(s): WO2007/147518

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263361-Bicycle saddle

2007263351-Tablets comprising candesartan cilexetil